PL366626A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer

Info

Publication number
PL366626A1
PL366626A1 PL01366626A PL36662601A PL366626A1 PL 366626 A1 PL366626 A1 PL 366626A1 PL 01366626 A PL01366626 A PL 01366626A PL 36662601 A PL36662601 A PL 36662601A PL 366626 A1 PL366626 A1 PL 366626A1
Authority
PL
Poland
Prior art keywords
diagnosis
therapy
compositions
methods
lung cancer
Prior art date
Application number
PL01366626A
Other languages
English (en)
Polish (pl)
Inventor
Steven G. Reed
Michael J. Lodes
Raodoh Mohamath
Heather Secrist
Darin R. Benson
Carol Yoseph Indirias
Robert A. Henderson
Steven P. Fling
Paul A. Algate
Mark Elliot
Jane Mannion
Michael D. Kalos
Original Assignee
Corixa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/738,973 external-priority patent/US20020110563A1/en
Application filed by Corixa Corporation filed Critical Corixa Corporation
Publication of PL366626A1 publication Critical patent/PL366626A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL01366626A 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer PL366626A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US53803700A 2000-03-29 2000-03-29
US58893700A 2000-06-05 2000-06-05
US64087800A 2000-08-18 2000-08-18
US23451700P 2000-09-22 2000-09-22
US70451200A 2000-11-01 2000-11-01
US09/738,973 US20020110563A1 (en) 2000-11-01 2000-12-14 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
PL366626A1 true PL366626A1 (en) 2005-02-07

Family

ID=27559252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366626A PL366626A1 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (7)

Country Link
JP (1) JP2004526401A (ja)
AU (1) AU2001261007A1 (ja)
CA (1) CA2404233A1 (ja)
CZ (1) CZ20023567A3 (ja)
HU (1) HUP0500345A2 (ja)
PL (1) PL366626A1 (ja)
WO (1) WO2001072295A2 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082212A1 (en) * 2000-07-20 2002-06-27 Millennium Pharmaceuticals, Inc. 7716, a novel human ATPase and uses therefor
WO2002092001A2 (en) * 2001-05-11 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2004035789A1 (en) * 2002-10-18 2004-04-29 Lg Life Sciences Ltd. Gene families associated with cancers
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge
AU2003295189A1 (en) * 2002-12-17 2004-07-09 Fondazione Centro San Raffaele Del Monte Tabor Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
CA2511858A1 (en) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
NZ552029A (en) 2004-06-25 2009-01-31 Takeda Pharmaceutical Metastin derivatives and use thereof
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
JP2007263896A (ja) * 2006-03-29 2007-10-11 Univ Nagoya 肺癌患者の術後予後予測のための生物マーカー及びその方法
TWI404726B (zh) 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
JP5648261B2 (ja) * 2006-12-20 2015-01-07 東レ株式会社 癌の検出方法
MX2011001445A (es) * 2008-08-05 2011-04-05 Toray Industries Metodo para detectar cancer.
BRPI0911926A2 (pt) 2008-08-05 2020-08-18 Toray Industries, Inc composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo.
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US8883966B2 (en) 2008-10-22 2014-11-11 Oncotherapy Science, Inc. RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
KR101801667B1 (ko) 2010-02-04 2017-11-27 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
HUE040012T2 (hu) 2010-02-04 2019-02-28 Toray Industries Gyógyászati ágens rák kezelésére és/vagy megelõzésére
EP2532365B1 (en) 2010-02-04 2016-05-04 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
MX340017B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
AU2011211699B2 (en) 2010-02-04 2015-01-22 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
AU2011211682B2 (en) 2010-02-04 2015-08-13 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
MX348577B (es) 2011-08-04 2017-06-20 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
CA2844030C (en) 2011-08-04 2019-09-03 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
JP6094220B2 (ja) 2011-08-04 2017-03-15 東レ株式会社 膵臓癌の検出方法
MX348578B (es) 2011-08-04 2017-06-20 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
DK2740489T3 (en) 2011-08-04 2017-01-16 Toray Industries Pharmaceutical composition for the treatment and / or prevention of pancreatic cancer
AU2012290957B2 (en) 2011-08-04 2017-04-20 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
US9181334B2 (en) 2011-08-04 2015-11-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
CA2865020C (en) 2012-02-21 2021-01-26 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
KR102005308B1 (ko) 2012-02-21 2019-07-30 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
ES2739612T3 (es) 2012-02-21 2020-02-03 Toray Industries Composición farmacéutica para el tratamiento de cáncer
DK2818483T3 (en) 2012-02-21 2017-10-23 Toray Industries Medical composition for the treatment and / or prevention of cancer
US9416193B2 (en) 2012-03-30 2016-08-16 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of liver cancer
MX357965B (es) 2012-03-30 2018-08-01 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar.
CA2879304C (en) 2012-07-19 2020-07-14 Toray Industries, Inc. Method for detecting cancer
EP2876447B1 (en) 2012-07-19 2019-11-20 Toray Industries, Inc. Method for detecting cancer
DK3031826T3 (en) 2013-08-09 2018-12-17 Toray Industries Pharmaceutical composition for the treatment and / or prevention of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2002540790A (ja) * 1999-04-02 2002-12-03 コリクサ コーポレイション 肺癌の治療および診断のための化合物ならびにその使用のための方法
WO2001079292A2 (en) * 2000-04-17 2001-10-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
EP1278844A2 (en) * 2000-05-03 2003-01-29 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
JP2004512023A (ja) * 2000-06-09 2004-04-22 コリクサ　コーポレイション 結腸癌の治療および診断のための組成物および方法

Also Published As

Publication number Publication date
JP2004526401A (ja) 2004-09-02
HUP0500345A2 (hu) 2005-07-28
AU2001261007A1 (en) 2001-10-08
CZ20023567A3 (cs) 2003-11-12
CA2404233A1 (en) 2001-10-04
WO2001072295A3 (en) 2002-08-22
WO2001072295A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1516049A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF LUNG CANCER
EP1515982A4 (en) METHODS AND COMPOSITIONS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
HUP0600780A2 (en) Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1446013A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1349485A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAL CARCINOMA
EP1420814A4 (en) COMPOSITIONS AND TECHNIQUES FOR THERAPY AND DIAGNOSIS OF BREAST CANCER
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)